(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers Says its US reimbursement code for EpiSwitch is now available. EpiSwitch Checkpoint-inhibitor Response Test is a test which predicts a patient's likely response to immune checkpoint inhibitor therapy. It was first launched in the US in February. Read More
Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers - Issued a proprietary laboratory code by the American Medical Association's Current Procedural Terminology Editorial Board. The code was issued for the EpiSwitch Checkpoint-inhibitor Response Test, a test which predicts a patient's likely response to immune checkpoint inhibitor therapy. Read More
(Alliance News) - Oxford BioDynamics PLC on Tuesday said it will need additional funding - either internal or external - by early 2023, as it posted a sharp drop in half-year revenue, sending its shares tumbling. Read More
(Alliance News) - Oxford BioDynamics PLC shares rose on Tuesday on news that the biotechnology firm's checkpoint inhibitor response test is now available in the UK. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
